印度各地结核病死亡率趋势:尽管有COVID-19大流行,但仍有改善
Karan Varshney1, Hinal Patel1, Shahed Kamal2
1School of Medicine, Deakin University, Waurn Ponds, AUS.
Cureus
|June 1, 2023
概括
尽管COVID-19期间全球结核病死亡人数上升,但印度的结核病死亡人数有所下降. 这项研究分析了2019年至2021年印度结核病死亡率的趋势,揭示了显著的减少.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 全球卫生安全 全球卫生安全
背景情况:
- 自2020年以来,COVID-19大流行严重影响了全球健康,在印度造成了结核病 (TB) 的双重负担.
- 了解COVID-19对印度结核病控制计划的影响对于公共卫生战略至关重要.
- 这项研究解决了在疫情期间分析印度结核病死亡率变化的需要.
研究的目的:
- 为了确定2019年至2021年期间印度各地结核病 (TB) 死亡率的变化.
- 评估COVID-19大流行对全国结核病死亡和特定弱势群体的影响.
主要方法:
- 描述了印度各地报告的结核病和COVID-19病例的趋势.
- 2019年,2020年和2021年国家和州级结核病死亡总数的比较.
- 分析了部落人口和艾滋病毒感染者的结核病死亡率,并计算了百分比变化.
主要成果:
- 与2019年相比,2020年结核病总死亡人数下降了15.4%,大多数印度州的结核病死亡人数有所减少.
- 在艾滋病毒感染者中,结核病死亡率在全国范围内下降了16.0%.
- 虽然与2020年相比,2021年结核病总死亡人数上升,但仍然低于2019年;在部落人口中,结核病死亡人数全国增加.
结论:
- 印度在COVID-19大流行期间结核病死亡人数下降,与全球结核病病例和死亡率上升的趋势形成鲜明对比.
- 需要进一步的研究来阐明导致印度结核病死亡人数下降的因素.
- 增加资源配置对于支持弱势群体至关重要,特别是结核病死亡率上升的州的部落人口.
更多相关视频
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
298
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.3K
相关概念视频
Pulmonary Tuberculosis I
293
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
293
Pulmonary Tuberculosis V
219
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
219
Pulmonary Tuberculosis II
282
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
282
Pulmonary Tuberculosis III
385
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
385
Pulmonary Tuberculosis IV
182
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
182
Prevalence and Incidence
650
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
650
